Clinical Trial Update: Functional Treatment Planning Utilizing 18-FDGal PET/CT in SBRT for Liver Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing functional treatment planning using 18-FDGal PET/CT to guide SBRT for liver metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases

Drugs mentioned

• 18-FDGal PET/CT tracer (fluorine-18 labeled galactose (18F-FDGal))

Snippet

Sponsor: University of Aarhus | Conditions: Liver Metastases | Phase 2 | Status: UNKNOWN